Brown Advisory’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,037
Closed -$216K 1139
2022
Q2
$216K Hold
10,037
﹤0.01% 1026
2022
Q1
$371K Hold
10,037
﹤0.01% 920
2021
Q4
$456K Sell
10,037
-270
-3% -$14.1K ﹤0.01% 903
2021
Q3
$653K Sell
10,307
-105
-1% -$8K ﹤0.01% 786
2021
Q2
$953K Sell
10,412
-231
-2% -$18.4K ﹤0.01% 712
2021
Q1
$725K Buy
10,643
+1,451
+16% +$113K ﹤0.01% 780
2020
Q4
$666K Buy
+9,192
New +$533K ﹤0.01% 733
2019
Q2
Sell
-19,165
Closed -$604K 1062
2019
Q1
$604K Buy
+19,165
New +$558K ﹤0.01% 932

Other funds holding CDNA

Brown Advisory's CDNA Position: Q3 2022 in Review

Brown Advisory sold out of CareDx (CDNA) in Q3 2022, closing a stake of 10,037 shares — an estimated $216K sold.

Brown Advisory first reported a position in CDNA in Q1 2019 and held it in 8 quarters. The position peaked at $953K in Q2 2021. 182 funds tracked by Wall St. Rank hold CDNA as of Q3 2022.

  • Brown Advisory reported no remaining CareDx position as of Q3 2022 after selling out during the quarter.
  • Brown Advisory sold 10,037 CareDx shares in Q3 2022, an estimated $216K.
  • Brown Advisory first reported a position in CareDx in Q1 2019 and held it in 8 quarters.
  • Brown Advisory's CareDx position peaked at $953K in Q2 2021.
  • 182 funds tracked by Wall St. Rank held CareDx as of Q3 2022.

Based on Brown Advisory's 13F filing for Q3 2022, filed 14 Nov 2022.